Cart
sales@molnova.com
Vimseltinib
Vimseltinib
Catalog No. M26081
DCC-3014 is a c-FMS (CSF-IR) and c-Kit dual inhibitor (IC50s: <0.01 μM and 0.1-1 μM) extracted from the patent WO2014145025A2 (Example 10).
| Size | Price / USD | Stock | Quantity |
| 5MG | 215 | In Stock |
|
| 10MG | 340 | In Stock |
|
| 25MG | 575 | In Stock |
|
| 50MG | 822 | In Stock |
|
| 100MG | 1107 | In Stock |
|
| 500MG | 2241 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameVimseltinib
-
Brief Description
-
Description
-
Storage
-
NoteResearch use only, not for human use.
-
Reference1.Kohno M, et al. Atrial and brain natriuretic peptides inhibit the endothelin-1 secretory response to angiotensin II in porcine aorta. Circ Res. 1992 Feb;70(2):241-7.
molnova catalog
related products
-
Gimsilumab
Gimsilumab (MORAb-022) is a humanized monoclonal antibody targeting granulocyte macrophage colony-stimulating factor for the study of COVID-19-induced inflammation and hypoxemia.
-
BLZ945
BLZ945 (BLZ-945) is a potent, selective, brain-penetrant CSF-1R inhibitor with biochemical IC50 of 1 nM.
-
Anumigilimab
Anumigilimab (CSL-324) is a fully human therapeutic anti-G-CSFR antibody with potential anti-tumor activity for the study of inflammation.
